Healthcare & Life Sciences
Red Queen Therapeutics
United States
series-a
series-a
Stage
1
Investors
About
Red Queen Therapeutics is a therapeutics company launched by Apple Tree Partners that develops antiviral treatments, including a pan-influenza program and compounds reported to protect against SARS‑CoV‑2, aimed at people at high risk from viral infections.
Explore Red Queen Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.